Uterine Cervical Neoplasm Diagnosed by Flexible Magnifying Endoscopy with Narrow Band Imaging.

cervical intraepithelial neoplasia endoscopic diagnosis magnifying endoscopy with narrow-band imaging

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
04 Nov 2020
Historique:
received: 23 09 2020
revised: 22 10 2020
accepted: 02 11 2020
entrez: 7 11 2020
pubmed: 8 11 2020
medline: 8 11 2020
Statut: epublish

Résumé

When detected early, uterine cervical cancer is one of the most successfully treatable forms of cancer. The diagnostic accuracy of the standard method, the Pap smear test followed by colposcopy, remains unsatisfactory. To improve detection of early-stage cervical cancer, new diagnostic tools for uterine cervical intraepithelial neoplasm (CIN) need to be developed. Magnifying endoscopy with narrow- band imaging (ME-NBI), which allows the visualization of the micro-structure as well as micro-vascularity of the mucosal surface, has excellent diagnostic ability for early gastrointestinal neoplasms. In our previous investigation, ME-NBI was efficacious for diagnosis of CIN. We herein report two notable cases of CIN3 that were diagnosed by ME-NBI that were not detected by colposcopy. These cases illustrate the usefulness of ME-NBI for diagnosis of early-stage uterine cervical neoplasms.

Identifiants

pubmed: 33158128
pii: diagnostics10110903
doi: 10.3390/diagnostics10110903
pmc: PMC7694180
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Gynecol Oncol. 2004 Dec;95(3):691-4
pubmed: 15581983
Oncol Lett. 2017 Jul;14(1):355-362
pubmed: 28693176
Ann Gastroenterol. 2015 Jan-Mar;28(1):41-48
pubmed: 25608626
Dig Endosc. 2019 Nov;31(6):653-661
pubmed: 31120161
Diagnostics (Basel). 2020 Jul 03;10(7):
pubmed: 32635269
Int J Gynaecol Obstet. 2016 Mar;132(3):259-65
pubmed: 26851054
Lancet. 2020 Feb 22;395(10224):591-603
pubmed: 32007142
Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:182-186
pubmed: 31302386
Int J Clin Oncol. 2018 Aug;23(4):707-714
pubmed: 29446041

Auteurs

Hideki Kobara (H)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa 761-0793, Japan.

Kunihisa Uchita (K)

Department of Gastroenterology, Kochi Red Cross Hospital, 2-13-51 Sinhonmachi, Kochi 780-8562, Japan.

Noriya Uedo (N)

Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 1-69, Otemae 3-chome, Chuo-ku, Osaka 541-8567, Japan.

Noriko Matsuura (N)

Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 1-69, Otemae 3-chome, Chuo-ku, Osaka 541-8567, Japan.

Noriko Nishiyama (N)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa 761-0793, Japan.

Kenji Kanenishi (K)

Department of Gynecology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa 761-0793, Japan.

Tsutomu Masaki (T)

Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa 761-0793, Japan.

Classifications MeSH